| Home | E-Submission | Sitemap | Editorial Office |  
top_img
Clinical and Molecular Hepatology Search > Browse Articles > Search



Combination of synbiotic and sitagliptin in nonalcoholic fatty liver disease: Is it better than sitagliptin alone?
Yong Kyun Cho
Clin Mol Hepatol.2018;24(3):299-301.   Published online September 7, 2018     
DOI: https://doi.org/10.3350/cmh.2018.1006
                              
Prognostic implications of trunk muscle mass in liver cirrhosis
Jimin Han, Won Kim
Clin Mol Hepatol.2018;24(3):297-298.   Published online September 10, 2018     
DOI: https://doi.org/10.3350/cmh.2018.0069
                              
Does the old-fashioned sofosbuvir plus ribavirin treatment in genotype 2 chronic hepatitis C patients still works for Koreans?
Jong Eun Yeon
Clin Mol Hepatol.2018;24(3):294-296.   Published online September 11, 2018     
DOI: https://doi.org/10.3350/cmh.2018.1009
                              
Recent update of the 2017 Korean Association for the Study of the Liver (KASL) treatment guidelines of chronic hepatitis C: Comparison of guidelines from other continents, 2017 AASLD/IDSA and 2016 EASL
Jong Eun Yeon
Clin Mol Hepatol.2018;24(3):278-293.   Published online May 2, 2018     
DOI: https://doi.org/10.3350/cmh.2018.1002
                              
KASL clinical practice guidelines for liver cirrhosis: Ascites and related complications
The Korean Association for the Study of the Liver (KASL)
Clin Mol Hepatol.2018;24(3):230-277.   Published online July 9, 2018     
DOI: https://doi.org/10.3350/cmh.2018.1005
                              Supplementary         Cited By 5
2017 KASL clinical practice guidelines management of hepatitis C: Treatment of chronic hepatitis C
The Korean Association for the Study of the Liver (KASL)
Clin Mol Hepatol.2018;24(3):169-229.   Published online August 10, 2018     
DOI: https://doi.org/10.3350/cmh.2018.1004
                                 Cited By 1
Living-donor liver transplantation for giant hepatic hemangioma with diffuse hemangiomatosis in an adult: a case report
Ju Hyun Lee, Chang Jin Yoon, Young Hoon Kim, Ho-Seong Han, Jai Young Cho, Haeryoung Kim, Eun Sun Jang, Jin-Wook Kim, Sook-Hyang Jeong
Clin Mol Hepatol.2018;24(2):163-168.   Published online July 19, 2017     
DOI: https://doi.org/10.3350/cmh.2017.0002
                              
Evolution of glomerular filtration rates and neutrophil gelatinase-associated lipocalin during treatment with direct acting antivirals
Alessio Strazzulla, Giuseppe Coppolino, Giorgio Settimo Barreca, Innocenza Gentile, Laura Rivoli, Maria Concetta Postorino, Maria Mazzitelli, Giuseppe Greco, Chiara Costa, Vincenzo Pisani, Nadia Marascio, Mariadelina Simeoni, Alfredo Focà, Giorgio Fuiano, Daniela Foti, Elio Gulletta, Carlo Torti
Clin Mol Hepatol.2018;24(2):151-162.   Published online April 24, 2018     
DOI: https://doi.org/10.3350/cmh.2017.0059
                                 Cited By 1
Comparison of surgical resection versus transarterial chemoembolization with additional radiation therapy in patients with hepatocellular carcinoma with portal vein invasion
Danbi Lee, Han Chu Lee, Jihyun An, Ju Hyun Shim, Kang Mo Kim, Young-Suk Lim, Young-Hwa Chung, Yung Sang Lee
Clin Mol Hepatol.2018;24(2):144-150.   Published online January 16, 2018     
DOI: https://doi.org/10.3350/cmh.2017.0041
                                 Cited By 1
Journal metrics of Clinical and Molecular Hepatology based on the Web of Science Core Collection
Sun Huh
Clin Mol Hepatol.2018;24(2):137-143.   Published online June 22, 2018     
DOI: https://doi.org/10.3350/cmh.2018.0018
                                 Cited By 2
Comparison of surgical resection versus transarterial chemoembolization with additional radiation therapy in patients with hepatocellular carcinoma with portal vein invasion
Jin Wook Chung
Clin Mol Hepatol.2018;24(2):135-136.   Published online February 22, 2018     
DOI: https://doi.org/10.3350/cmh.2018.1001
                              
Strategic application of radiotherapy for hepatocellular carcinoma
Seo Hee Choi, Jinsil Seong
Clin Mol Hepatol.2018;24(2):114-134.   Published online February 14, 2018     
DOI: https://doi.org/10.3350/cmh.2017.0073
                                 Cited By 3
Management of chronic hepatitis B patients in immunetolerant phase: what latest guidelines recommend
Grace Lai-Hung Wong
Clin Mol Hepatol.2018;24(2):108-113.   Published online January 22, 2018     
DOI: https://doi.org/10.3350/cmh.2017.0068
                                 Cited By 1
Microbiota, a key player in alcoholic liver disease
Anne-Marie Cassard, Dragos Ciocan
Clin Mol Hepatol.2018;24(2):100-107.   Published online December 22, 2017     
DOI: https://doi.org/10.3350/cmh.2017.0067
                                 Cited By 9
Epidemiology of alcoholic liver disease in Korea
Jae Young Jang, Dong Joon Kim
Clin Mol Hepatol.2018;24(2):93-99.   Published online March 16, 2018     
DOI: https://doi.org/10.3350/cmh.2017.0079
                                 Cited By 3
Metastatic endophthalmitis and thyroid abscess complicating Klebsiella pneumoniae liver abscess
Seon-Jae Kim, Seong Taek Chu, Keun Sook Lee, Seung Woo Nam, Jong Kyoung Choi, Joo Won Chung, Hyeok Choon Kwon
Clin Mol Hepatol.2018;24(1):88-91.   Published online June 28, 2017     
DOI: https://doi.org/10.3350/cmh.2016.0066
                              
Picroside II attenuates fatty acid accumulation in HepG2 cells via modulation of fatty acid uptake and synthesis
Hiteshi Dhami-Shah, Rama Vaidya, Shobha Udipi, Srividhya Raghavan, Shiny Abhijit, Viswanathan Mohan, Muthuswamy Balasubramanyam, Ashok Vaidya
Clin Mol Hepatol.2018;24(1):77-87.   Published online December 19, 2017     
DOI: https://doi.org/10.3350/cmh.2017.0039
                              Supplementary      
Serum matrix metalloproteinase-1 level represents disease activity as opposed to fibrosis in patients with histologically proven nonalcoholic steatohepatitis
Wataru Ando, Hiroaki Yokomori, Nobuhiro Tsutsui, Eigoro Yamanouchi, Yutaka Suzuki, Masaya Oda, Yutaka Inagaki, Katsuya Otori, Isao Okazaki
Clin Mol Hepatol.2018;24(1):61-76.   Published online November 20, 2017     
DOI: https://doi.org/10.3350/cmh.2017.0030
                              Supplementary         Cited By 1
Resection plane-dependent error in computed tomography volumetry of the right hepatic lobe in living liver donors
Heon-Ju Kwon, Kyoung Won Kim, Bohyun Kim, So Yeon Kim, Chul Seung Lee, Jeongjin Lee, Gi Won Song, Sung Gyu Lee
Clin Mol Hepatol.2018;24(1):54-60.   Published online August 1, 2017     
DOI: https://doi.org/10.3350/cmh.2017.0023
                                 Cited By 3
Clinical implication of hepatic volumetry for living donor liver transplantation
Woo Kyoung Jeong
Clin Mol Hepatol.2018;24(1):51-53.   Published online March 22, 2018     
DOI: https://doi.org/10.3350/cmh.2018.1003
                              
Role of liver transplantation in severe alcoholic hepatitis
Ravi Daswani, Ashish Kumar, Praveen Sharma, Vikas Singla, Naresh Bansal, Anil Arora
Clin Mol Hepatol.2018;24(1):43-50.   Published online January 10, 2018     
DOI: https://doi.org/10.3350/cmh.2017.0027
                                 Cited By 3
Prevention and management of gastroesophageal varices
Yeon Seok Seo
Clin Mol Hepatol.2018;24(1):20-42.   Published online December 18, 2017     
DOI: https://doi.org/10.3350/cmh.2017.0064
                                 Cited By 2
Current epidemiology and clinical characteristics of autoimmune liver diseases in South Korea
Sook-Hyang Jeong
Clin Mol Hepatol.2018;24(1):10-19.   Published online January 5, 2018     
DOI: https://doi.org/10.3350/cmh.2017.0066
                                 Cited By 2
Epidemiology of liver cancer in South Korea
Bo Hyun Kim, Joong-Won Park
Clin Mol Hepatol.2018;24(1):1-9.   Published online December 18, 2017     
DOI: https://doi.org/10.3350/cmh.2017.0112
                                 Cited By 7
Complete response of advanced hepatocellular carcinoma to sorafenib : another case and a comprehensive review
Tae Suk Kim, Ji Hoon Kim, Baek hui Kim, Young-Sun Lee, Yang Jae Yoo, Seong Hee Kang, Sang-June Suh, Young Kul Jung, Yeon Seok Seo, Hyung Joon Yim, Jong Eun Yeon, Kwan Soo Byun
Clin Mol Hepatol.2017;23(4):340-346.   Published online June 20, 2017     
DOI: https://doi.org/10.3350/cmh.2016.0070
                                 Cited By 2
Efficacy and safety of entecavir versus lamivudine over 5 years of treatment: A randomized controlled trial in Korean patients with hepatitis B e antigen-negative chronic hepatitis B
Kwan Sik Lee, Young-Oh Kweon, Soon-Ho Um, Byung-Ho Kim, Young Suk Lim, Seung Woon Paik, Jeong Heo, Heon-Ju Lee, Dong Joon Kim, Tae Hun Kim, Young-Sok Lee, Kwan Soo Byun, Daeghon Kim, Myung Seok Lee, Kyungha Yu, Dong Jin Suh
Clin Mol Hepatol.2017;23(4):331-339.   Published online September 26, 2017     
DOI: https://doi.org/10.3350/cmh.2016.0040
                              
Clinical characteristics of patients with chronic hepatitis B who developed genotypic resistance to entecavir: Real-life experience
Hong Joo Kim, Yong Kyun Cho, Woo Kyu Jeon, Byung Ik Kim
Clin Mol Hepatol.2017;23(4):323-330.   Published online September 5, 2017     
DOI: https://doi.org/10.3350/cmh.2017.0005
                                 Cited By 3
Efficacy and safety of sofosbuvir-based regimens for treatment in chronic hepatitis C genotype 1 patients with moderately impaired renal function
Hyun Phil Shin, Ji-Ae Park, Blaire Burman, Richard A. Kozarek, Asma Siddique
Clin Mol Hepatol.2017;23(4):316-322.   Published online August 22, 2017     
DOI: https://doi.org/10.3350/cmh.2016.0087
                                 Cited By 8
Lamivudine: fading into the mists of time
Jonggi Choi, Young-Suk Lim
Clin Mol Hepatol.2017;23(4):314-315.   Published online November 28, 2017     
DOI: https://doi.org/10.3350/cmh.2017.0110
                              
Is it possible to predict the development of an entecavir resistance mutation in patients with chronic hepatitis B in clinical practice?
Joon Yeul Nam, Jeong-Hoon Lee
Clin Mol Hepatol.2017;23(4):311-313.   Published online December 4, 2017     
DOI: https://doi.org/10.3350/cmh.2017.0069
                              
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | Next
E-Submission
Email Alert
Author's Index
EndNote Style file download
The Korean Association for the Study of the Liver
The Liver Week 2019
SCImago Journal & Country Rank
PubMed Central
PubMed
Scopus
KoreaMed
KoMCI
ScienceCentral
DOAJ
GoogleScholar
Similarity Check
Crossref Cited-by Linking
CrossMark
Funder Registry
ORCID
MeSH on Demand
COPE
Editorial Office
The Korean Association for the Study of the Liver
Room A1210, 53 Mapo-daero(MapoTrapalace, Dowha-dong), Mapo-gu, Seoul, 04158, Korea
TEL: +82-2-703-0051   FAX: +82-2-703-0071    E-mail: kasl@kams.or.kr
About |  Browse Articles |  Current Issue |  For Authors and Reviewers
Copyright © The Korean Association for the Study of the Liver. All rights reserved.         
COUNTER
TODAY : 564
TOTAL : 113456